Michael McCartney
Profile
Michael McCartney served as the Chief Executive Officer of SciKon Innovation, Inc. from 2017 to 2018.
Prior to that, he was the Chief Commercial Officer at Cancer Genetics, Inc. and Vyant Bio, Inc. McCartney received an undergraduate degree from Indiana University of Pennsylvania and an MBA from LaSalle University.
Former positions of Michael McCartney
| Companies | Position | End |
|---|---|---|
| SciKon Innovation, Inc. | Chief Executive Officer | 2018-04-30 |
| VYANT BIO, INC. | Corporate Officer/Principal | - |
| CANCER GENETICS, INC. | Corporate Officer/Principal | - |
Training of Michael McCartney
| Indiana University of Pennsylvania | Undergraduate Degree |
| LaSalle University | Masters Business Admin |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| VYANT BIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Cancer Genetics, Inc.
 Cancer Genetics, Inc. Medical SpecialtiesHealth Technology Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus: NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ. | Health Technology |
| SciKon Innovation, Inc. |
- Stock Market
- Insiders
- Michael McCartney
